Search Results

Structural Analysis of DFG-in and DFG-out Dual Src-Abl Inhibitors Sharing a Common Vinyl Purine Template

Authors: Zhou, Tianjun; Commodore, Lois; Huang, Wei-Sheng; Wang, Yihan; Sawyer, Tomi K.; Shakespeare, William C.; Clackson, Tim; Zhu, Xiaotian; Dalgarno, David C.

Source: Chemical Biology & Drug Design, Volume 75, Number 1, January 2010 , pp. 18-28(11)

Publisher: Blackwell Publishing

Imatinib: Pleural effusion: case report

Source: Reactions, Volume 1, Number 1279, 2009-11-21 , pp. 21-22(2)

Publisher: Adis International

T-regulatory cell response in psoriasis and changes with imatinib therapy

Author: Thachil, J.

Source: Clinical & Experimental Dermatology, Volume 34, Number 8, December 2009 , pp. e1022-e1022(1)

Publisher: Blackwell Publishing

ABCG2: the key to chemoresistance in cancer stem cells?

Authors: An, Yi; Ongkeko, Weg M

Source: Expert Opinion on Drug Metabolism and Toxicology, Volume 5, Number 12, December 2009 , pp. 1529-1542(14)

Publisher: Informa Healthcare

Imatinib: Acute liver failure: case report

Source: Reactions, Volume 1, Number 1280, 2009-11-28 , pp. 26-27(2)

Publisher: Adis International

Imatinib: Heart failure: case report

Source: Reactions, Volume 1, Number 1280, 2009-11-28 , pp. 27-27(1)

Publisher: Adis International

Imatinib: Gastrointestinal Burkitt's lymphoma: case report

Source: Reactions, Volume 1, Number 1280, 2009-11-28 , pp. 27-27(1)

Publisher: Adis International

Issues of Imatinib and Pregnancy Outcome

Author: Apperley, Jane

Source: Journal of the National Comprehensive Cancer Network (JNCCN), Volume 7, Number 10, November 2009 , pp. 1050-1058(9)

Publisher: Cold Spring Publishing, LLC

New Agents in the Treatment of Chronic Myelogenous Leukemia

Authors: Pinilla-Ibarz, Javier; Quintás-Cardama, Alfonso

Source: Journal of the National Comprehensive Cancer Network (JNCCN), Volume 7, Number 9, October 2009 , pp. 1028-1037(10)

Publisher: Cold Spring Publishing, LLC

Sunitinib: A Multitargeted Receptor Tyrosine Kinase Inhibitor in the Era of Molecular Cancer Therapies

Authors: Papaetis, Georgios S.; Syrigos, Kostas N.

Source: BioDrugs, Volume 23, Number 6, 1 December 2009 , pp. 377-389(13)

Publisher: Adis International

A short low-dose imatinib trial allows rapid identification of responsive patients in hypereosinophilic syndromes

Authors: Intermesoli, Tamara; Delaini, Federica; Acerboni, Sara; Salmoiraghi, Silvia; Spinelli, Orietta; Guerini, Vittoria; Vannucchi, Alessandro M.; Mappa, Silvia; Rossi, Giuseppe; Rossi, Valentina; Di Bona, Eros; Paratore, Simona; Carobbio, Alessandra; Rambaldi, Alessandro; Barbui, Tiziano; Bassan, Renato

Source: British Journal of Haematology, Volume 147, Number 5, December 2009 , pp. 681-685(5)

Publisher: Blackwell Publishing

Cost-Effectiveness Study Comparing Imatinib with Interferon-α for Patients with Newly Diagnosed Chronic-Phase (CP) Chronic Myeloid Leukemia (CML) from the Chinese Public Health-Care System Perspective (CPHSP)

Authors: Chen, Zi; Wang, Chun; Xu, Xiaoping; Feng, Weiwei

Source: Value in Health, Volume 12, Supplement 3, November/December 2009 , pp. S85-S88(1)

Publisher: Blackwell Publishing

Immunosuppression and atypical infections in CML patients treated with dasatinib at 140 mg daily

Authors: Sillaber, C.; Herrmann, H.; Bennett, K.; Rix, U.; Baumgartner, C.; Böhm, A.; Herndlhofer, S.; Tschachler, E.; Superti-Furga, G.; Jäger, U.; Valent, P.

Source: European Journal of Clinical Investigation, Volume 39, Number 12, December 2009 , pp. 1098-1109(12)

Publisher: Blackwell Publishing

Insulin-like growth factors and insulin-like growth factor-binding proteins in relation to disease status and incidence of hypoglycaemia in patients with a gastrointestinal stromal tumour

Authors: Rikhof, B.; van Doorn, J.; Suurmeijer, A. J. H.; Rautenberg, M. W.; Groenen, P. J. T. A.; Verdijk, M. A. J.; Jager, P. L.; de Jong, S.; Gietema, J. A.; van der Graaf, W. T. A.

Source: Annals of Oncology, Volume 20, Number 9, 24 September 2009 , pp. 1582-1588(7)

Publisher: Oxford University Press

Triptolide abrogates oncogene FIP1L1-PDGFRα addiction and induces apoptosis in hypereosinophilic syndrome

Authors: Jin, Yanli; Chen, Qi; Lu, Zhongzheng; Chen, Bo; Pan, Jingxuan

Source: Cancer Science, Volume 100, Number 11, November 2009 , pp. 2210-2217(8)

Publisher: Blackwell Publishing

Peripheral neuropathy on imatinib treatment for chronic myeloid leukaemia: suspected adverse drug interaction with amlodipine

Source: Internal Medicine Journal, Volume 39, Number 10, October 2009 , pp. 708-708(1)

Publisher: Blackwell Publishing

Imatinib: Peripheral nerve disorder: case report

Source: Reactions, Volume 1, Number 1274, 2009-10-17 , pp. 24-24(1)

Publisher: Adis International

Interaction of nilotinib, dasatinib and bosutinib with ABCB1 and ABCG2: implications for altered anti-cancer effects and pharmacological properties

Authors: Hegedűs, C; Özvegy-Laczka, C; Apáti, Á; Magócsi, M; Német, K; Őrfi, L; Kéri, G; Katona, M; Takáts, Z; Váradi, A; Szakács, G; Sarkadi, B

Source: British Journal of Pharmacology, Volume 158, Number 4, October 2009 , pp. 1153-1164(12)

Publisher: Blackwell Publishing

Midostaurin (PKC412) inhibits immunoglobulin E-dependent activation and mediator release in human blood basophils and mast cells

Authors: Krauth, M.-T.; Mirkina, I.; Herrmann, H.; Baumgartner, C.; Kneidinger, M.; Valent, P.

Source: Clinical & Experimental Allergy, Volume 39, Number 11, November 2009 , pp. 1711-1720(10)

Publisher: Blackwell Publishing

in vitro Anti-leukaemia Activity of Pyrrolo[1,2-b][1,2,5]benzothiadiazepines (PBTDs)

Authors: Marfe, Gabriella; Stefano, Carla D.

Source: Recent Patents on Anti-Cancer Drug Discovery, Volume 5, Number 1, January 2010 , pp. 58-68(11)

Publisher: Bentham Science Publishers